BR vs CTSH
Broadridge Financial Solutions and Cognizant
Cognizant is the larger company at $21B against $16B. On trailing earnings CTSH is the cheaper of the two at a P/E of 12.9 against 17.2, a gap that is only a bargain if the two are growing at similar rates. Over the past year CTSH returned -14% against -31% for BR. The RyuScore puts CTSH ahead, 82 against 77 out of 100.
| Figure | BR | CTSH |
|---|---|---|
| Last close | $165 | $59.19 |
| Market cap | $16B | $21B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 17.2 | 12.9 |
| Dividend yield | 2.4% | 2.1% |
| 1-year return | -31% | -14% |
| 5-year return | +6.1% | -16% |
| RyuScoresector-relative, 1–10 | 77/100 | 82/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Broadridge Financial Solutions
Revenue of $2.2B in Q4 2026, net income $398M. Its largest reported line is Recurring Fee Revenue Regulatory, 30% of the disclosed total.
Cognizant
Revenue of $5.4B in Q1 2026, net income $662M. Its largest reported line is Health Sciences, 32% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.